Considering that these drug-resistant cancer cells show an increased overexpression of ABCB1 on their membranes, it is assumed that combination treatment with P-gp inhibitors can increase the possibility of successful treatments to shrink tumor size over a relatively long time and delay tumor relapse (Figure 1). This evidence concerns the gene PGP and cancer.